ААР — Американская академия педиатрии (American Academy of Pediatrics)
ABC — алгоритм неотложной помощи «дыхательные пути-дыхание-кровообращение» (Airways-Breathing-Circulation)
АВСА3 — белковый член АТФ-связывающей кассеты АЗ
АВСВ11 — ген АТФ-связывающей кассеты, 11-й член подсемейства В (ATP-binding cassette, subfamily В member 11)
АВСВ4 — ген АТФ-связывающей кассеты, 4-й член подсемейства В (ATP-binding cassette 4 gene)
АВСС2 — ген, кодирующий 2-й член подсемейства С ABCDE — алгоритм неотложной помощи «дыхательные пути-дыхание-кровообращение-неврологический статус-внешний вид» (Airways-Breathing-Circulation-Disability-Exposure)
ABCG5/G8 — гетеродимер переносчика АТФ-связывающей кассеты ABCG5 и ABCG8 (Th eheterodimer of ATP-binding cassette transporter ABCG5 and ABCG8)
AC — до еды (при назначениях) — ante cibum
АСЕР — Американская коллегия врачей неотложной помощи (American College of Emergency Physicians)
ACOG — Американская коллегия акушеров и гинекологов (American College of Obstetricians and Gynecologists)
AHA — Американская кардиологическая ассоциация (American Heart Association)
AIS — аденокарцинома in situ (adenocarcinoma in situ)
ALTE — очевидное опасное для жизни событие (apparent life-threatening event)
APLS — курсы расширенных реанимационных мероприятий в педиатрии, спонсируемые Американской академией педиатрии и Американской коллегией врачей неотложной помощи (Advanced Pediatric Life Support)
AUC — площадь под фармакокинетической кривой (area under the curve)
AVPU — шкала для оценки уровня сознания («в ясном сознании»; «реакция на вербальные раздражители»; «реакция на боль»; «без сознания») (alert, verbal, pain, unresponsive)
ABCC2 - АТФ-связывающих кассет (ATP-binding cassette sub-family C member 2)
mTOR — мишень рапамицина в клетках млекопитающих (mammalian target ofrapamycin)
NB! — важно, обратить внимание (Nota bene)
NCI — Национальный институт рака (National Cancer Institute)
NICE — Национальный институт здоровья и клинического совершенствования (качества медицинской помощи) Великобритании (National Institute for Health and Clinical Excellence)
NK — естественные клетки-киллеры (natural killer)
NMDA — N-метил-D-аспартат (N-methyl-D-aspartate)
NMDA — N-метил-D-аспартатные рецепторы
NNT — число больных, которых необходимо пролечить, чтобы достичь какого-то указанного эффекта (Number Need to Treatment)
OR — отношение шансов (odds ratio)
paCO2 — парциальное давление углекислого газа в артериальной крови
PALS — курсы расширенных реанимационных мероприятий в педиатрии (Pediatric Advanced Life Support)
PANDAS — аутоиммунное нейропсихиатрическое расстройство в детском возрасте, ассоциированное со стрептококковой инфекцией (Pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection)
PANS — острый нейропсихиатрический синдром в детском возрасте (Pediatric acute-onset neuropsychiatric syndrome)
paO2 — парциальное давление кислорода в артериальной крови
PAS — фуксинсернистая кислота, реактив Шиффа (periodic acid-Shiff)
PC — после еды (при назначениях) — post cibum рСO2 — парциальное давление углекислого газа PCSK-9 — пропротеиновая конвертаза субтилизин-кексинового типа 9 (proprotein convertase subtilisin/kexin type 9)
PD — плотность мощности (power density)
PD-1 — программируемая клеточная смерть 1 (англ. programmed cell death 1)
PFAPA — периодическая лихорадка с афтозным стоматитом, фарингитом и лимфаденитом (Periodic Fevers with Aphthous stomatitis, Pharyngitis and Adenitis)
PIM — показатель летального исхода у детей (Pediatric Index of Mortality)
piO2 — парциальное давление кислорода
во вдыхаемом воздухе
рО2 — парциальное давление кислорода
POLG — субъединица ДНК-полимеразы у
POP — пролапс тазовых органов (pelvic organ prolapse) POP-Q — количественная оценка пролапса тазовых органов (Pelvic Organ Prolapse Quantification)
PRISA II — оценка риска госпитализации у детей II (Pediatric Risk of Admission)
PRISM — риск летального исхода у детей (Pediatric Risk of Mortality)
PRN — при (по) необходимости (Pro re nata — при возникновении обстоятельств)
PRSS — ген сериновой протеазы
PS. — примечание (Post scriptum)
PUVA-терапия — псорален-ультрафиолет А-терапия (psoralen and ultraviolet А)
Q#H — каждые # часов (при назначениях) — quaque... hora
QAM — каждое утро (при назначениях) — quaque ante meridiem
QPM — каждый вечер (при назначениях) — quaque post meridiem
RAG — ген, активирующий рекомбиназу
REMS — Программа по оценке и снижению риска (Risk Evaluation and Mitigation Strategy)
RePEAT — пересмотренный инструмент для оценки педиатрической неотложной медицинской помощи (Revised Pediatric Emergency Assessment Tool)
RF — ревматоидный фактор
Rh — резус(-фактор)
Rh«+» — резус-положительный
Rh«-» — резус-отрицательный
ROCA — Алгоритм риска развития рака яичников (Risk of Ovarian Cancer Algorithm)
ROHHAD — быстро развивающееся ожирение с дисфункцией гипоталамуса, гиповентиляцией и спонтанной дисрегуляцией (rapid-onset obesity with hypothalamic dysfunction, hypoventilation and autonomic dysregulation)
ROMA — Алгоритм риска наличия злокачественной опухоли яичника (Risk of Ovarian Malignancy Algorithm)
RR — относительный риск (relative risk или risk ratio)
RW — реакция Вассермана (reaction of Wassermann)
SaO2 — сатурация артериальной крови кислородом
SatO2 — насыщение крови кислородом
SCJ — зона перехода плоского эпителия в цилиндрический (Scuamocolumnar Junction)
ScvO2 — насыщение кислородом центральной венозной крови (central venous oxygen saturation)
SD — стандартное отклонение (standart deviation) SEER — эпидемиология эпиднадзора и данных о конечных результатах (Surveillance Epidemiology and End Result)
SFTPA — ген сурфактантного белка A
SFTPB — ген сурфактантного белка В
SFTPC — ген сурфактантного белка С
SILS — хирургия единого лапароскопического доступа (single-incision laparoscopic surgery)
В ходе подготовки статей по абортам в гинекологии для пользователей сайта МедУнивер использованы труды следующих авторов:
Abbassi-Ghanavati M, Casey BM, Spong CY et al. Pregnancy outcomes in women with thyroid peroxidase antibodies. Obstet Gynecol 116:381, 2010
Accreditation Council for Graduate Medical Education: Clarification on requirements regarding family planning and contraception. Review Committee for Obstetrics and Gynecology. 2017.
Achilles SL, Reeves MF, Society of Family Planning: Prevention of infection after induced abortion: release date October 2010: SFP guideline 20102. Contraception 83(4):295, 2011
Allen RH, Goldberg AB: Cervical dilation before first-trimester surgical abortion (<14 weeks gestation). Contraception 93(4):277, 2016
Amb?hl LMM, Leonhard AK, Widen Zakhary C et al. Human papillomavirus infects placental trophoblast and Hofbauer cells, but appears not to play a causal role in miscarriage and preterm labor. Acta Obstet Gynecol Scand 96(10):1188, 2017
American College of Obstetricians and Gynecologists: College statement of policy: abortion policy. 2014.
American College of Obstetricians and Gynecologists: The limits of conscientious refusal in reproductive medicine. Committee Opinion No. 385, November 2007, Reaffirmed 2016a
American College of Obstetricians and Gynecologists, Society of Family Planning: Medical management of first-trimester abortion. Practice Bulletin No. 143, March 2014, Reaffirmed 2016b
American College of Obstetricians and Gynecologists: Prevention of Rh D alloimmunization. Practice Bulletin No. 181, August 2017a
American College of Obstetricians and Gynecologists: Second-trimester abortion. Practice Bulletin No. 135, June 2013, Reaffirmed 2017b
American College of Obstetricians and Gynecologists: Antiphospholipid syndrome. Practice Bulletin No. 132, December 2012, Reaffirmed 2017c
American College of Obstetricians and Gynecologists: Early pregnancy loss. Practice Bulletin No. 200, August 2019b/2018a
American College of Obstetricians and Gynecologists: Induced abortion and breast cancer risk. Committee Opinion No. 434, June 2009, Reaffirmed 2018b
American College of Obstetricians and Gynecologists: Inherited thrombophilias in pregnancy. Practice Bulletin No. 197, July 2018c
American College of Obstetricians and Gynecologists: Moderate caffeine consumption during pregnancy. Committee Opinion No. 462, August 2010, Reaffirmed 2018d
American College of Obstetricians and Gynecologists: Prevention of infection after gynecologic procedures. Practice Bulletin No. 195, June 2018e
American College of Obstetricians and Gynecologists: Tubal ectopic pregnancy. Practice Bulletin No. 193, March 2018f
American College of Obstetricians and Gynecologists: Ultrasound in pregnancy. Practice Bulletin No. 175, December 2016, Reaffirmed 2018g
American College of Obstetricians and Gynecologists: Abortion training and education. Committee Opinion No. 612, November 2014, Reaffirmed 2019a
American College of Obstetricians and Gynecologists: Increasing access to abortion. Committee Opinion No. 613, November 2014, Reaffirmed 2019b
American College of Obstetricians and Gynecologists, American Society of Anesthesiologists: Nonobstetric surgery during pregnancy. Committee Opinion No. 775, April 2019c
American College of Radiology: ACR Manual on Contrast Media, Version 10.3, Reston, American College of Radiology, 2018
American Society for Reproductive Medicine: Definitions of infertility and recurrent pregnancy loss. Fertil Steril 99(1):63, 2013
American Society for Reproductive Medicine: Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertil Steril 98 (5):1103, 2012
American Society for Reproductive Medicine: Removal of myomas in asymptomatic patients to improve fertility and/or reduce miscarriage rate: a guideline. Fertil Steril 108(3):416, 2017
American Society for Reproductive Medicine: Subclinical hypothyroidism in the infertile female population: a guideline. Fertil Steril 104(3):545, 2015
Andersen AM, Andersen PK, Olsen J et al. Moderate alcohol intake during pregnancy and risk of fetal death. Int J Epidemiol 41(2):405, 2012
Andersen SL, Olsen J, Wu CS et al. Spontaneous abortion, stillbirth and hyperthyroidism: a Danish population-based study. Eur Thyroid J 3(3):164, 2014
Arredondo F, Noble LS: Endocrinology of recurrent pregnancy loss. Semin Reprod Med 1:33, 2006
Atrash HK, Strauss LT, Kendrick JS et al. The relation between induced abortion and ectopic pregnancy. Obstet Gynecol 89(4):512, 1997
Avalos LA, Roberts SC, Kaskutas LA et al. Volume and type of alcohol during early pregnancy and the risk of miscarriage. Subst Use Misuse 49:1437, 2014
Balsells M, Garc?a-Patterson A, Corcoy R: Systematic review and meta-analysis on the association of prepregnancy underweight and miscarriage. Eur J Obstet Gynecol Reprod Biol 207:73, 2016
Barber JC, Cockwell AE, Grant E: Is karyotyping couples experiencing recurrent miscarriage worth the cost? BJOG 117:885, 2010
Barlow S, Sullivan FM: Reproductive Hazards of Industrial Chemicals: an Evaluation of Animal and Human Data. New York, Academic Press, 1982
Barnhart K, Mennuti MT, Benjamin I et al. Prompt diagnosis of ectopic pregnancy in an emergency department setting. Obstet Gynecol 84(6):1010, 1994
Barnhart K, van Mello NM, Bourne T et al. Pregnancy of unknown location: a consensus statement of nomenclature, definitions, and outcome. Fertil Steril 95(3):857, 2011
Barnhart KT, Sammel MD, Appleby D et al. Does a prediction model for pregnancy of unknown location developed in the UK validate on a US population? Hum Reprod 25(10):2434, 2010
Baud D, Goy G, Jaton K et al. Role of Chlamydia trachomatis in miscarriage. Emerg Infect Dis 17(9):1630, 2011
Bednarek PH, Creinin MD, Reeves MF et al. Immediate versus delayed IUD insertion after uterine aspiration. N Engl J Med 364(21):2208, 2011
Belloc S, Cohen-Bacrie P, Benkhalifa M et al. Effect of maternal and paternal age on pregnancy and miscarriage rates after intrauterine insemination. Reprod Biomed Online 17(3):392, 2008
Bellver J, Ayll?n Y, Ferrando M et al. Female obesity impairs in vitro fertilization outcome without affecting embryo quality. Fertil Steril 93(2):447, 2010a
Bellver J, Meseguer M, Muriel L et al. Y chromosome microdeletions, sperm DNA fragmentation and sperm oxidative stress as causes of recurrent spontaneous abortion of unknown etiology. Hum Reprod 25(7):1713, 2010b
Bhattacharya S, Townend J, Bhattacharya S: Recurrent miscarriage: are three miscarriages one too many? Analysis of a Scottish population-based database of 151,021 pregnancies. Eur J Obstet Gynecol Reprod Biol 150:24, 2010
Bick RL, Baker WF Jr: наследственная и приобретенная тромбофилия во время беременности. In Bick RL (ed): Hematological Complications in Obstetrics, Pregnancy, and Gynecology. Cambridge, Cambridge University Press, 2006, p 122
Biggs MA, Upadhyay UD, McCulloch CE et al. Women’s mental health and well-being 5 years after receiving or being denied an abortion: a prospective, longitudinal cohort Study. JAMA Psychiatry 74(2): 169, 2017
Boots CE, Bernardi LA, Stephenson MD: Frequency of euploid miscarriage is increased in obese women with recurrent early pregnancy loss. Fertil Steril 102(2):455, 2014
Borgatta L, Burnhill MS, Tyson J et al. Early medical abortion with methotrexate and misoprostol. Obstet Gynecol 97:11, 2001
Branch DW, Gibson M, Silver RM: Recurrent miscarriage. N Engl J Med 363: 18, 2010
Brent RL: Saving lives and changing family histories: appropriate counseling of pregnant women and men and women of reproductive age, concerning the risk of diagnostic radiation exposures during and before pregnancy. Am J Obstet Gynecol 200(1):4, 2009
Brezina PR, Kutteh WH: Classic and cutting-edge strategies for the management of early pregnancy loss. Obstet Gynecol Clin North Am 41(1):1, 2014
Brigham SA, Conlon C, Farquhason RG: A longitudinal study of pregnancy outcome following idiopathic recurrent miscarriage. Hum Reprod 14(11): 2868, 1999
Brown ZA, Selke S, Zeh J et al. The acquisition of herpes simplex virus during pregnancy. N Engl J Med 337:509, 1997
Bryant AG, Grimes DA, Garrett JM et al. Second-trimester abortion for fetal anomalies or fetal death: labor induction compared with dilation and evacuation. Obstet Gynecol 117(4):788, 2011
Casey BM, Dashe JS, Wells CE и др.: субклинический гипотиреоз и исходы беременности. Obstet Gynecol 105(2):239, 2005
Casta?eda R, Lechuga D, Ramos RI et al. Endemic goiter in pregnant women: utility of the simplified classification of thyroid size by palpation and urinary iodine as screening tests. BJOG 109:1366, 2002
Centers for Disease Control and Prevention: Clostridium sordellii toxic shock syndrome after medical abortion with mifepristone and intravaginal misoprostol—United States and Canada, 2001–2005. MMWR 54(29):724, 2005
Chen L, Hu R: Thyroid autoimmunity and miscarriage: a meta-analysis. Clin Endocrinol 74(4):513, 2011
Clark CA, Spitzer KA, Crowther MA et al. Incidence of postpartum thrombosis and preterm delivery in women with antiphospholipid antibodies and recurrent pregnancy loss. J Rheumatol 34(5):992, 2007a
Clark EA, Silver RM, Branch DW: Do antiphospholipid antibodies cause preeclampsia and HELLP syndrome? Curr Rheumatol Rep 9:219, 2007b
Clark K, Ji H, Feltovich H et al: Mifepristone-induced cervical ripening: structural, biomechanical, and molecular events. Am J Obstet Gynecol 194: 1391, 2006
Cleland K, Creinin M, Nucatola D et al. Significant adverse events and outcomes after medical abortion. Obstet Gynecol 121(1):166, 2013
Clifford K, Rai R, Watson H et al. Does suppressing luteinizing hormone secretion reduce the miscarriage rate? Results of a randomized controlled trial. BMJ 312:1508, 1996
Clowse ME, Jamison M, Myers E et al. A national study of the complications of lupus in pregnancy. Am J Obstet Gynecol 199:127.e1, 2008
Cocksedge KA, Saravelos SH, Metwally M et al. How common is polycystic ovary syndrome in recurrent miscarriage? Reprod Biomed Online 19(4):572, 2009
Condous G, Okaro E, Khalid A, Bourne T: Do we need to follow up complete miscarriages with serum human chorionic gonadotrophin levels? BJOG 112: 827, 2005
Condous G, Van Calster B, Kirk E et al. Clinical information does not improve the performance of mathematical models in predicting the outcome of pregnancies of unknown location. Fertil Steril 88(3):572, 2007
Connolly A, Ryan DH, Stuebe AM et al. Reevaluation of discriminatory and threshold levels for serum ?-hCG in early pregnancy. Obstet Gynecol 121(1):65, 2013
Coyaji K, Krishna U, Ambardekar S et al. Are two doses of misoprostol after mifepristone for early abortion better than one? BJOG 114(3):271, 2007
Craig TB, Ke RW, Kutteh WH: Increase prevalence of insulin resistance in women with a history of recurrent pregnancy loss. Fertil Steril 78:487, 2002
Creinin MD, Huang X, Westhoff C et al. Factors related to successful misoprostol treatment for early pregnancy failure. Obstet Gynecol 107:901, 2006
Creinin MD, Schreiber CA, Bednarek P et al. Mifepristone and misoprostol administered simultaneously versus 24 hours apart for abortion: a randomized controlled trial. Obstet Gynecol 109(4):885, 2007
Daif JL, Levie M, Chudnoff S et al. Group A Streptococcus causing necrotizing fasciitis and toxic shock syndrome after medical termination of pregnancy. Obstet Gynecol 113(2 Pt 2):504, 2009
Danco Laboratories: Ordering mifeprex. 2019.
Danco Laboratories: Patient agreement form. 2016.
Dao B, Blum J, Thieba B et al. Is misoprostol a safe, effective and acceptable alternative to manual vacuum aspiration for postabortion care? Results from a randomized trial in Burkina Faso, West Africa. BJOG 114(11):1368, 2007
Dashe JS, Cunningham FG: Genetics. In Cunningham FG, Leveno KJ, Bloom SL, et al (eds): Williams Obstetrics, 25th ed. New York, McGraw-Hill, 2018, p 262
De Vivo A, Mancuso A, Giacobbe A et al. Thyroid function in women found to have early pregnancy loss. Thyroid 20(6):633, 2010
Devaseelan P, Fogarty PP, Regan L: Human chorionic gonadotropin for threatened abortion. Cochrane Database Syst Rev 5:DC007422, 2010
Devi Wold AS, Pham N, Arici A: Anatomic factors in recurrent pregnancy loss. Semin Reprod Med 1:25, 2006
Di Simone N, Meroni PL, D’Asta M et al. Pathogenic role of anti-beta2- glycoprotein I antibodies on human placenta: functional effects related to implantation and roles of heparin. Hum Reprod Update 13(2):189, 2007
Donahue JG, Kieke BA, King JP et al. Association of spontaneous abortion with receipt of inactivated influenza vaccine containing H1N1pdm09 in 2010–11 and 2011–12. Vaccine 35(40):5314, 2017
Doubilet PM, Benson CB, Bourne T et al. Diagnostic criteria for nonviable pregnancy early in the first trimester. N Engl J Med 369(15):1443, 2014
Drake P, Driscoll AK, Mathews TJ: Cigarette smoking during pregnancy: United States, 2016. NCHS Data Brief 305:1, 2018
Dranitsaris G, Johnston M, Poirier S et al. Are health care providers who work with cancer drugs at an increased risk for toxic events? A systematic review and meta-analysis of the literature. J Oncol Pharm Pract 2:69, 2005
Du Y, Chen L, Lin J et al. Chromosomal karyotype in chorionic villi of recurrent spontaneous abortion patients. Biosci Trends 12(1):32, 2018
Dunford A, Fyfe R: Combination therapy with mifepristone and misoprostol for the management of first trimester miscarriage: Improved success. Aust N Z Obstet Gynaecol 58(4):438, 2018
Eiben B, Bartels I, Bahr-Prosch S et al. Cytogenetic analysis of 750 spontaneous abortions with the direct-preparation method of chorionic villi and its implications for studying genetic causes of pregnancy wastage. Am J Hum Genet 47:656, 1990
Empson M, Lassere M, Craig J et al. Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database Syst Rev 2:CD002859, 2012
Erkan D, Kozora E, Lockshin MD: Cognitive dysfunction and white matter abnormalities in antiphospholipid syndrome. Pathophysiology 18(1):93, 2011
European Society of Human Reproduction and Embryology: ESHRE information for couples with recurrent pregnancy loss. 2017.
Fekih M, Fathallah K, Ben Regaya L et al. Sublingual misoprostol for first trimester termination of pregnancy. Int J Gynaecol Obstet 109(1):67, 2010
Feldman DM, Timms D, Borgida AF: Toxoplasmosis, parvovirus, and cytomegalovirus in pregnancy. Clin Lab Med 30(3):709, 2010
Feodor Nilsson S, Andersen PK, Strandberg-Larsen K et al. Risk factors for miscarriage from a prevention perspective: a nationwide follow-up study. BJOG 121(11):1375, 2014
Fischer J, Colls P, Esudero T et al. Preimplantation genetic diagnosis (PGD) improves pregnancy outcome for translocation carriers with a history of recurrent losses. Fertil Steril 94(1):283, 2010
Fischer M, Bhatnagar J, Guarner J et al. Fatal toxic shock syndrome associated with Clostridium sordellii after medical abortion. N Engl J Med 353:2352, 2005
Floyd RL, Decoufle P, Hungerford DW: Alcohol use prior to pregnancy recognition. Am J Prev Med 17:101, 1999
Food and Drug Administration: Labeling for mifepristone (Mifeprex). 2016.
Fox MC, Krajewski CM: Cervical preparation for second-trimester surgical abortion prior to 20 weeks’ gestation: SFP Guideline #2013-4. Contraception 89(2):75, 2014
Franssen MTM, Korevaar JC, van der Veen F et al. Reproductive outcome after chromosome analysis in couples with two or more miscarriages: case-control study. BMJ 332:750, 2006
Freedman L, Landy U, Steinauer J: Obstetrician-gynecologist experiences with abortion training: physician insights from a qualitative study. Contraception 81(6):525, 2010
Fritz MA, Speroff L, (eds): Recurrent early pregnancy loss. In Clinical Gynecologic Endocrinology and Infertility, 8th ed. Philadelphia, Lippincott Williams & Wilkins, 2011, p 1220
Gao J, Liu C, Yao F et al. Array-based comparative genomic hybridization is more informative than conventional karyotyping and fluorescence in situ hybridization in the analysis of first-trimester spontaneous abortion. Mol Cytogenet 5(1):33, 2012
Gaskins AJ, Toth TL, Chavarro JE: Prepregnancy nutrition and early pregnancy outcomes. Curr Nutr Rep 4(3):265, 2015
Glueck CJ, Want P, Goldenberg N et al. Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin. Hum Reprod 17:2858, 2002
Goldberg AB, Dean G, Kang MS et al. Manual versus electric vacuum aspiration for early first-trimester abortion: a controlled study of complication rates. Акушер Гинекол 103:101, 2004
Goldberg AB, Fortin JA, Drey EA et al. Cervical preparation before dilation and evacuation using adjunctive misoprostol or mifepristone compared with overnight osmotic dilators alone: a randomized controlled trial. Obstet Gynecol 126(3):599, 2015
Goldenberg M, Sivan E, Sharabi Z et al. Reproductive outcome following hysteroscopic management of intrauterine septum and adhesions. Hum Reprod 10:2663, 1995
Gonzalez CH, Marques-Dias MJ, Kim CA et al. Congenital abnormalities in Brazilian children associated with misoprostol misuse in first trimester of pregnancy. Lancet 351(9116):1624, 1998
Gracia CR, Sammel MD, Chittams J et al. Risk factors for spontaneous abortion in early symptomatic first-trimester pregnancies. Obstet Gynecol 106:993, 2005
Greene MF: Spontaneous abortions and major malformations in women with diabetes mellitus. Semin Reprod Endocrinol 17:127, 1999
Grimes DA: Estimation of pregnancy-related mortality risk by pregnancy outcome, United States, 1991 to 1999. Am J Obstet Gynecol 194:92, 2006
Grossman D, Grindlay K, Altshuler AL et al. Induced abortion provision among a national sample of obstetrician-gynecologists. Obstet Gynecol 133:477, 2019
Grossman D, White K, Hopkins K et al. The public health threat of anti-abortion legislation. Contraception 89:73, 2014
Guelinckx I, Devlieger R, Vansant G: Reproductive outcome after bariatric surgery: a critical review. Hum Reprod Update 15(2):189, 2009
Guest J, Chien PF, Thomson MA et al. Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol. BJOG 114(2):207, 2007
Guttmacher Institute: An overview of abortion laws. 2019.
Haahr T, Zacho J, Br?uner M et al. Reproductive outcome of patients undergoing in vitro fertilisation treatment and diagnosed with bacterial vaginosis or abnormal vaginal microbiota: a systematic PRISMA review and meta-analysis. BJOG 126(2):200, 2019
Haas DM, Hathaway TJ, Ramsey PS: Progestogen for preventing miscarriage in women with recurrent miscarriage of unclear etiology. Cochrane Database Syst Rev 10:CD003511, 2018
Haddad LB, Wall KM, Mehta CC et al. Trends of and factors associated with live-birth and abortion rates among HIV-negative women. Am J Obstet Gynecol 216(1):71, 2017
Haddow JE, McClain MR, Palomaki GE et al. Thyroperoxidase and thyroglobulin antibodies in early pregnancy and placental abruption. Obstet Gynecol 117:287, 2011
Hamoda H, Ashok PW, Flett GM et al. A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation. BJOG 112:1102, 2005
Hannafin B, Lovecchio F, Blackburn P: Do Rh-negative women with first trimester spontaneous abortions need Rh immune globulin? Am J Obstet Gynecol 24:487, 2006
Harris LH, Cooper A, Rasinski KA et al. Obstetrician-gynecologists’ objections to and willingness to help patients obtain an abortion. Obstet Gynecol 118(4):905, 2011
Herrera C, Meehan R, Podduturi V et al. Maternal death due to Clostridium novyi in an injection drug user. Obstet Gynecol 128(4):876, 2016
Heuser C, Dalton J, Macpherson C et al. Idiopathic recurrent pregnancy loss recurs at similar gestational ages. Am J Obstet Gynecol 203(4):343.e1, 2010
Hide G, Morley EK, Hughes JM et al. Evidence for high levels of vertical transmission in Toxoplasma gondii. Parasitology 136(14):1877, 2009
Hirahara F, Andoh N, Sawai K et al. Hyperprolactinemic recurrent miscarriage and results of randomized bromocriptine treatment trials. Fertil Steril 70(2):246, 1998
Ho CS, Bhatnagar J, Cohen AL et al. Undiagnosed cases of fatal Clostridium-associated toxic shock in Californian women of childbearing age. Am J Obstet Gynecol 201:459.e1, 2009
Hoffman BL, Cunningham FG: First-trimester loss. In Cunningham FG, Leveno KL, Bloom SL, et al (eds): Williams Obstetrics, 25th ed. New York, McGraw-Hill, 2018, p 354
Homer H, Saridogan E: Uterine artery embolization for fibroids is associated with an increased risk of miscarriage. Fertil Steril 94(1):324, 2010
Honkanen H, Piaggio G, Hertzen H et al. WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion. BJOG 111(7):715, 2004
Hudson MM: Reproductive outcomes for survivors of childhood cancer. Obstet Gynecol 116:1171, 2010
Hyoun SC, Obi?an SG, Scialli AR: Teratogen update: methotrexate. Birth Defects Res A Clin Mol Teratol 94(4):187, 2012
Ibrahim Y, Johnstone E: The male contribution to recurrent pregnancy loss. Transl Androl Urol 7(3 suppl):S317, 2018
Inman S: More than 400 abortion restrictions passed since 2011—states working overtime to cut access. 2018.
Jacobs PA, Hassold TJ: The origin of chromosomal abnormalities in spontaneous abortion. In Porter IH, Hook EB (eds): Human Embryonic and Fetal Death. New York, Academic Press, 1980, p 289
Jain JK, Harwood B, Meckstroth KR et al. A prospective randomized, double-blinded, placebo-controlled trial comparing mifepristone and vaginal misoprostol to vaginal misoprostol alone for elective termination of early pregnancy. Hum Reprod 17:1477, 2002
Jaslow CR, Carney JL, Kutteh WH: Diagnostic factors identified in 1020 women with two versus three or more recurrent pregnancy losses. Fertil Steril 93(4):1234, 2010
Johns J, Jauniaux E: Threatened miscarriage as a predictor of obstetric outcome. Obstet Gynecol 107:845, 2006
Jun SH, Ginsburg ES, Racowsky C et al. Uterine leiomyomas and their effect on in vitro fertilization outcome: a retrospective study. J Assist Reprod Genet 18:139, 2001
Kajii T, Ferrier A, Niikawa N et al. Anatomic and chromosomal anomalies in 639 spontaneous abortions. Hum Genet 55:87, 1980
Kapp N, Lohr PA, Ngo TD et al. Cervical preparation for first trimester surgical abortion. Cochrane Database Syst Rev 2:CD007207, 2010
Katz A, Ben-Arie A, Lurie S et al. Reproductive outcome following hysteroscopic adhesiolysis in Asherman’s syndrome. Int J Fertil Menopausal Stud 41:462, 1996
Kc S, Hemminki E, Gissler M et al. Perinatal outcomes after induced termination of pregnancy by methods: a nationwide register-based study of first births in Finland 1996–2013. PLoS One 12(9):e0184078, 2017
Khalife D, Ghazeeri G, Kutteh W: Review of current guidelines for recurrent pregnancy loss: new strategies for optimal evaluation of women who may be superfertile. Semin Perinatol 43(2):105, 2019
Khashan AS, Quigley EM, McNamee R et al. Increased risk of miscarriage and ectopic pregnancy among women with irritable bowel syndrome. Clin Gastroenterol Hepatol 10(8):902, 2012
Khooshideh M, Yarmohammadi N, Shahriari A et al. Sublingual misoprostol plus laminaria for cervical preparation before surgical management of late first trimester missed abortions, a randomized controlled trial. J Matern Fetal Neonatal Med 30(3):317, 2017
Kim C, Barnard S, Neilson JP et al. Medical treatments for incomplete miscarriage. Cochrane Database Syst Rev 1:CD007223, 2017
Kleinhaus K, Perrin M, Friedlander Y et al. Paternal age and spontaneous abortion. Obstet Gynecol 108:369, 2006
Koert E, Malling GM, Sylvest R et al. Recurrent pregnancy loss: couples’ perspectives on their need for treatment, support and follow up. Hum Reprod 34(2):291, 2019
Krassas GE, Poppe K, Glinoer D: Thyroid function and human reproductive health. Endo Rev 31:702, 2010
Krieg SA, Shahine LK, Lathi RB: Environmental exposure to endocrine-disrupting chemicals and miscarriage. Fertil Steril 106(4):941, 2016
Kulier R, Kapp N, G?lmezoglu AM et al. Medical methods for first trimester abortion. Cochrane Database Syst Rev 11:CD002855, 2011
Kuon RJ, Togawa R, Vomstein K et al. Higher prevalence of colonization with Gardnerella vaginalis and gram-negative anaerobes in patients with recurrent miscarriage and elevated peripheral natural killer cells. J Reprod Immunol 120:15, 2017
Kutteh WH, Hinote CD: Antiphospholipid antibody syndrome. Obstet Gynecol Clin North Am 41(1):113, 2014
Levy BS, Ness DL, Weinberger SE: Consensus guidelines for facilities performing outpatient procedures: evidence over ideology. Obstet Gynecol 133(2):255, 2019
Liauw J, Dineley B, Gerster K et al. Abortion training in Canadian obstetrics and gynecology residency programs. Contraception 94:478, 2016
Ling N, Lawson E, von Scheven E: Adverse pregnancy outcomes in adolescents and young women with systemic lupus erythematosus: a national estimate. Pediatr Rheumatol Online J 16(1):26, 2018
Lis R, Rowhani-Rahbar A, Manhart LE: Mycoplasma genitalium infection and female reproductive tract disease: a meta-analysis. Clin Infect Dis 61(3):418, 2015
Lui S, Song L, Cram DS et al. Traditional karyotyping versus copy number variation sequencing for detection of chromosomal abnormalities associated with spontaneous miscarriage. Ultrasound Obstet Gynecol 46:472, 2015
Luise C, Jermy K, May C et al. Outcome of expectant management of spontaneous first trimester miscarriage: observational study. BMJ 324:873, 2002
Lupo PJ, Symanski E, Waller DK et al. Maternal exposure to ambient levels of benzene and neural tube defects among offspring, Texas, 1999–2004. Environ Health Perspect 119:397, 2011
Lykke JA, Dideriksen KL, Lidegaard ? et al. First-trimester vaginal bleeding and complications later in pregnancy. Obstet Gynecol 115:935, 2010
Lyman M, Mpofu JJ, Soud F: Maternal and perinatal outcomes in pregnant women with suspected Ebola virus disease in Sierra Leone, 2014. Int J Gynaecol Obstet 142(1):71, 2018
Maconochie N, Doyle P, Prior S et al. Risk factors for first trimester miscarriage— results from a UK-population-based case-control study. BJOG 114:170, 2007
Madden T, Westhoff C: Rates of follow-up and repeat pregnancy in the 12 months after first-trimester induced abortion. Obstet Gynecol 113:663, 2009
Mazze RI, K?ll?n B: Reproductive outcome after anesthesia and operation during pregnancy: a registry study of 5405 cases. Am J Obstet Gynecol 161: 1178, 1989
McMillan M, Porritt K, Kralik D et al. Influenza vaccination during pregnancy: a systematic review of fetal death, spontaneous abortion, and congenital malformation safety outcomes. Vaccine 33(18):2108, 2015
Meites E, Zane S, Gould C: Fatal Clostridium sordellii infections after medical abortions. N Engl J Med 363(14):1382, 2010
Meroni PL, Tedesco F, Locati M et al. Anti-phospholipid antibody mediated fetal loss: still an open question from a pathogenic point of view. Lupus 19: 453, 2010
Metwally M, Saravelos SH, Ledger WL et al. Body mass index and risk of miscarriage in women with recurrent miscarriage. Fertil Steril 94(1):290, 2010
Mills JL: Cocaine, smoking, and spontaneous abortion. N Engl J Med 340(5):380, 1999
Mills JL, Simpson JL, Driscoll SG et al. Incidence of spontaneous abortion among normal women and insulin-dependent diabetic women whose pregnancies were identified within 21 days of conception. N Engl J Med 319:1618, 1988
Miyakis S, Lockshin MD, Atsumi T et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4:295, 2006
Morales-Su?rez-Varela M, Nohr EA, Olsen J et al. Potential combined effects of maternal smoking and coffee intake on foetal death within the Danish National Cohort. Eur J Public Health 28(2):315, 2018
Moreau C, Kaminski M, Ancel PY et al. Previous induced abortions and the risk of very preterm delivery: results of the EPIPAGE study. BJOG 112:430, 2005
Nahum GG: Uterine anomalies. How common are they, and what is their distribution among subtypes? J Reprod Med 43(10):877, 1998
National Academies of Science Engineering and Medicine: The safety and quality of abortion care in the United States. 2018.
Nawaz FH, Rizvi J: Continuation of metformin reduces early pregnancy loss in obese Pakistani women with polycystic ovarian syndrome. Gynecol Obstet Invest 69(3):184, 2010
Neilson JP, Gyte GM, Hickey M et al. Medical treatments for incomplete miscarriage (less than 24 weeks). Cochrane Database Syst Rev 3:CD007223, 2013
Ness RB, Grisso JA, Hirschinger N et al. Cocaine and tobacco use and the risk of spontaneous abortion. N Engl J Med 340(5):333, 1999
Newmann S, Dalve-Endres A, Drey EA: Society of Family Planning clinical guidelines. Cervical preparation for surgical abortion from 20 to 24 weeks’ gestation. Contraception 77(4):308, 2008
Nguyen NT, Blum J, Durocher J et al. A randomized controlled study comparing 600 versus 1200 ?g oral misoprostol for medical management of incomplete abortion. Contraception 72:438, 2005
Nielsen A, Hannibal CG, Lindekilde BE et al. Maternal smoking predicts the risk of spontaneous abortion. Acta Obstet Gynecol Scand 85(9):1057, 2006
Niinimoki M, Pouta A, Bloigu A et al. Immediate complications after medical compared with surgical termination of pregnancy. Obstet Gynecol 114:795, 2009
Nurmohamed L, Moretti ME, Schechter T et al. Outcome following high-dose methotrexate in pregnancies misdiagnosed as ectopic. Am J Obstet Gynecol 205:533.e1, 2011
Oakeshott P, Hay P, Hay S et al. Association between bacterial vaginosis or chlamydial infection and miscarriage before 16 weeks’ gestation: prospective, community based cohort study. BMJ 325:1334, 2002
Palomba S, Falbo A, Orio F Jr et al. Effect of preconceptional metformin on abortion risk in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. Fertil Steril 92(5):1646, 2009
Pearl JP, Price RR, Tonkin AE et al. SAGES guidelines for the use of laparoscopy during pregnancy. Surg Endosc 31(10):3767, 2017
Pineles BL, Park E, Samet JM: Systematic review and meta-analysis of miscarriage and maternal exposure to tobacco smoke during pregnancy. Am J Epidemiol 179(7):807, 2014
Platteau P, Staessen C, Michiels A et al. Preimplantation genetic diagnosis for aneuploidy screening in patients with unexplained recurrent miscarriages. Fertil Steril 83(2):393, 2005
Pocius KD, Bartz D, Maurer R et al. Serum human chorionic gonadotropin (hCG) trend within the first few days after medical abortion: a prospective study. Contraception 95(3):263, 2017
Popescu F, Jaslow CR, Kutteh WH: Recurrent pregnancy loss evaluation combined with 24-chromosome microarray of miscarriage tissue provides a probable or definite cause of pregnancy loss in over 90% of patients. Hum Reprod 33(4):579, 2018
Prasad P, Singh N, Das B et al. Differential expression of circulating Th1/Th2/ Th17 cytokines in serum of Chlamydia trachomatis-infected women undergoing incomplete spontaneous abortion. Microb Pathog 110:152, 2017
Pymar HC, Creinin MD, Schwartz JL: Mifepristone followed on the same day by vaginal misoprostol for early abortion. Contraception 64:87, 2001
Quinn PA, Shewchuck AB, Shuber J et al. Efficacy of antibiotic therapy in preventing spontaneous pregnancy loss among couples colonized with genital mycoplasmas. Am J Obstet Gynecol 145:239, 1983a
Quinn PA, Shewchuck AB, Shuber J et al. Serologic evidence of Ureaplasma urealyticum infection in women with spontaneous pregnancy loss. Am J Obstet Gynecol 145:245, 1983b
Raghavan S, Comendant R, Digol I et al. Two-pill regimens of misoprostol after mifepristone medical abortion through 63 days’ gestational age: a randomized controlled trial of sublingual and oral misoprostol. Contraception 79(2):84, 2009
Rajcan-Separovic E: Next generation sequencing in recurrent pregnancy loss-approaches and outcomes. Eur J Med Genet Apr 13, 2019 [Epub ahead of print]
Ramasamy R, Scovell JM, Kovac JR et al. Fluorescence in situ hybridization detects increased sperm aneuploidy in men with recurrent pregnancy loss. Fertil Steril 103(4):906, 2015
Ramzy AM, Sattar M, Amin Y et al. Uterine myomata and outcome of assisted reproduction. Hum Reprod 13:198, 1998
Rand JH, Wu XX, Quinn AS et al. The annexin A5-mediated pathogenic mechanism in the antiphospholipid syndrome: role in pregnancy losses and thrombosis. Lupus 19(4):460, 2010
Raymond E, Grimes D: The comparative safety of legal induced abortion and childbirth in the United States. Obstet Gynecol 119(2, Part 1):215, 2012
Reeves MF, Smith KJ, Creinin MD: Contraceptive effectiveness of immediate compared with delayed insertion of intrauterine devices after abortion. Obstet Gynecol 109:1286, 2007
Reichman DE, Laufer MR: Congenital uterine anomalies affecting reproduction. Best Pract Res Clin Obstet Gynecol 24(2):193, 2010
Robertshaw I, Khoury J, Abdallah ME et al. The effect of paternal age on outcome in assisted reproductive technology using the ovum donation model. Reprod Sci 21(5):590, 2014
Robinson L, Gallos ID, Conner SJ et al. The effect of sperm DNA fragmentation on miscarriage rates: a systematic review and meta-analysis. Hum Reprod 27(10):2908, 2012
Rowland AS, Baird DD, Shore DL et al. Nitrous oxide and spontaneous abortion in female dental assistants. Am J Epidemiol 141:531, 1995
Salim R, Regan L, Woelfer B et al. A comparative study of the morphology of congenital uterine anomalies in women with and without a history of recurrent first trimester miscarriage. Hum Reprod 18:162, 2003
Saraswat L, Bhattacharya S, Maheshwari A et al. Maternal and perinatal outcome in women with threatened miscarriage in the first trimester: a systematic review. BJOG 117:245, 2010
Saravelos SH, Cocksedge KA, Li TC: Prevalence and diagnosis of congenital uterine anomalies in women with reproductive failure: a critical appraisal. Hum Reprod Update 14(5):415, 2008
Saravelos SH, Yan J, Rehmani H et al. The prevalence and impact of fibroids and their treatment on the outcome of pregnancy in women with recurrent miscarriage. Hum Reprod 26:3274, 2011
Savaris RF, Silva de Moraes G, Cristovam RA et al. Are antibiotics necessary after 48 hours of improvement in infected/septic abortions? A randomized controlled trial followed by a cohort study. Am J Obstet Gynecol 204:301. e1, 2011
Savitz DA, Chan RL, Herring AH et al. Caffeine and miscarriage risk. Epidemiology 19:55, 2008
Saygili-Yilmaz E, Yildiz S, Erman-Akar M et al. Reproductive outcome of septate uterus after hysteroscopic metroplasty. Arch Gynecol Obstet 4:289, 2003
Schaff EA, Fielding SL, Westhoff C et al. Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion. A randomized trial. JAMA 284:1948, 2000
Scheller NM, Pasternak B, M?lgaard-Neilsen D et al. Quadrivalent HPV vaccination and the risk of adverse pregnancy outcomes. N Engl J Med 376(13): 1223, 2017
Schneider D, Golan A, Langer R et al. Outcome of continued pregnancies after first and second trimester cervical dilatation by laminaria tents. Obstet Gynecol 78:1121, 1991
Schreiber CA, Creinin MD, Atrio J, el at: Mifepristone pretreatment for the medical management of early pregnancy loss. N Engl Med 378: 2161, 2018
Seckin B, Sarikaya E, Oruc AS et al. Office hysteroscopic findings in patients with two, three, and four or more, consecutive miscarriages. Eur J Contracept Reprod Health Care 17(5):393, 2012
Shah PS, Zao J, Knowledge synthesis group of determinants of preterm/LBW births: induced termination of pregnancy and low birthweight and preterm birth: a systematic review and meta-analyses. BJOG 116(11):1425, 2009
Shannon C, Brothers LP, Philip NM et al. Ectopic pregnancy and medical abortion. Obstet Gynecol 104(1):161, 2004
Shannon C, Wiebe E, Jacot F: Regimens of misoprostol with mifepristone for early medical abortion: a randomized trial. BJOG 113:621, 2006
Shimoni N, Davis A, Ramos M et al. Timing of copper intrauterine device insertion after medical abortion. Obstet Gynecol 118(3):623, 2011
Silver RM, Branch DW, Goldenberg R et al. Nomenclature for pregnancy outcomes. Obstet Gynecol 118(6):1402, 2011
Smith LF, Ewings PD, Guinlan C: Incidence of pregnancy after expectant, medical, or surgical management of spontaneous first trimester miscarriage: long term follow-up of miscarriage treatment (MIST) randomized controlled trial. BMJ 339:b3827, 2009
Soler A, Morales C, Mademont-Soler I et al. Overview of chromosome abnormalities in first trimester miscarriages: A series of 1,011 consecutive chorionic villi sample karyotypes. Cytogenet Genome Res 152(2):81, 2017
Steinauer J, Drey EA, Lewis R et al. Obstetrics and gynecology resident satisfaction with an integrated, comprehensive abortion rotation. Obstet Gynecol 105:1335, 2005
Steinauer JE, Turk JK, Pomerantz T et al. Abortion training in US obstetrics and gynecology residency programs. Am J Obstet Gynecol 219:86.e1, 2018
Stephenson MD: Management of recurrent early pregnancy loss. J Reprod Med 51:303, 2006
Stephenson MD, Kutteh WH, Purkiss S et al. Intravenous immunoglobulin and idiopathic secondary recurrent miscarriage: a multicentered randomized placebo-controlled trial. Hum Reprod 25(9):2203, 2010
Streeter GL: Focal deficiencies in fetal tissues and their relation to intra-uterine amputation. Carnegie Institute of Washington 1930, Publication No. 414, p 5
Strzelczk JJ, Damilakis J, Marx MV et al. Facts and controversies about radiation exposure, part 2: low-level exposures and cancer risk. J Am Coll Radiol 4(1):32, 2007
Stubblefield PG, Monson RR, Schoenbaum SC et al. Fertility after induced abortion: a prospective follow-up study. Obstet Gynecol 63(2):186, 1984
Stulberg DB, Dude AM, Dahlguist I et al. Abortion provision among practicing obstetrician-gynecologists. Obstet Gynecol 118(3):609, 2011
Sugiura-Ogasawara M, Ebara T, Yamada Y et al. Adverse pregnancy and perinatal outcome in patients with recurrent pregnancy loss: Multiple imputation analyses with propensity score adjustment applied to a large-scale birth cohort of the Japan Environment and Children’s Study. Am J Reprod Immunol 81(1):e13072, 2019
Sullivan AE, Silver RM, LaCoursiere DY et al. Recurrent fetal aneuploidy and recurrent miscarriage. Obstet Gynecol 104:784, 2004
Sunkara SK, Khairy M, El-Toukhy T et al. The effect of intramural fibroids without uterine cavity involvement on the outcome of IVF treatment: a systematic review and meta-analysis. Hum Reprod 25(2):418, 2010
Temmerman M, Lopita MI, Sanghvi HC et al. The role of maternal syphilis, gonorrhoea and HIV-1 infections in spontaneous abortion. Int J STD AIDS 3:418, 1992
Templeton A, Grimes D: A request for abortion. N Engl J Med 365(23):2198, 2011
Thangaratinam S, Tan A, Knox E et al. Association between thyroid autoantibodies and miscarriage and preterm birth: meta-analysis of evidence. BMJ 342:d2616, 2011
Tharapel AT, Tharapel SA, Bannerman RM: Recurrent pregnancy losses and parental chromosome abnormalities: a review. BJOG 92:899, 1985
Tongsong T, Srisomboon J, Wanapirak C et al. Pregnancy outcome of threatened abortion with demonstrable fetal cardiac activity: a cohort study. J Obstet Gynaecol 21:331, 1995
Torre A, Huchon C, Bussieres L et al. Immediate versus delayed medical treatment for first-trimester miscarriage: a randomized trial. Am J Obstet Gynecol 206:215.e1, 2012
Trinder J, Brocklehurst P, Porter R et al. Management of miscarriage: expectant, medical, or surgical? Results of randomized controlled trial (miscarriage treatment (MIST) trial). BMJ 332(7552):1235, 2006
Tzeng CR, Hwang JL, Au HK et al. Sonographic patterns of the endometrium in assessment of medical abortion outcomes. Contraception 88(1):153, 2013
Upadhyay UD, Desai S, Zlidar V et al. Incidence of emergency department visits and complications after abortion. Obstet Gynecol 125(1):175, 2015
Valli E, Zupi E, Marconi D et al. Hysteroscopic findings in 344 women with recurrent spontaneous abortion. J Am Assoc Gynecol Laparosc 8(3):398, 2001
van den Boogaard E, Kaandorp SP, Franssen MT et al. Consecutive or non-consecutive recurrent miscarriage: is there any difference in carrier status? Hum Reprod 25(6):1411, 2010
van den Bosch T, Daemen A, Van Schoubroeck D et al. Occurrence and outcome of residual trophoblastic tissue: a prospective study. J Ultrasound Med 27(3):357, 2008
Vargas FR, Schuler-Faccini L, Brunoni D et al. Prenatal exposure to misoprostol and vascular disruption defects: a case-control study. Am J Med Genet 95(4):302, 2000
Vartian CV, Septimus EJ: Tricuspid valve group B streptococcal endocarditis following elective abortion. Review Infect Dis 13:997, 1991
Venetis CA, Papadopoulos SP, Campo R et al. Clinical implications of congenital uterine anomalies: a meta-analysis of comparative studies. Reprod Biomed Online 29(6):665, 2014
Vissenberg R, van den Boogaard E, van Wely M et al. Treatment of thyroid disorders before conception and in early pregnancy: a systematic review. Hum Reprod Update 18(4):360, 2012
Vitez SF, Forman EJ, Williams Z: Preimplantation genetic diagnosis in early pregnancy loss. Semin Perinatol 43:116, 2019
von Hertzen H, Honkanen H, Piaggio G et al. WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion. I: Efficacy. BJOG 110:808, 2003
von Hertzen H, Huong NTM, Piaggio G et al. Misoprostol dose and route after mifepristone for early medical abortion: a randomized controlled noninferiority trial. BJOG 117(10):1186, 2010
von Hertzen H, Piaggio G, Huong NT et al. Efficacy of two intervals and two routes of administration of misoprostol for termination of early pregnancy: a randomised controlled equivalence trial. Lancet 369(9577):1938, 2007
von Hertzen H, Piaggio G, Wojdyla D et al. Two mifepristone doses and two intervals of misoprostol administration for termination of early pregnancy: a randomized factorial controlled equivalence trial. BJOG 116(3):381, 2009
Weiss J, Malone F, Vidaver J et al. Threatened abortion: a risk factor for poor pregnancy outcome—a population based screening study (the FASTER Trial). Am J Obstet Gynecol 187:S70, 2002
Weng X, Odouki R, Li DK: Maternal caffeine consumption during pregnancy and the risk of miscarriage: a prospective cohort study. Am J Obstet Gynecol 198:279.e1, 2008
Westreich D, Cates J, Cohen M et al. Smoking, HIV, and risk of pregnancy loss. AIDS 31(4):553, 2017
White KE, Carroll E, Grossman D: Complications from first-trimester aspiration abortion: a systematic review of the literature. Contraception 92(5): 422, 2015
Wijesiriwardana A, Bhattacharya S, Shetty A et al. Obstetric outcome in women with threatened miscarriage in the first trimester. Obstet Gynecol 107:557, 2006
Wilcox AF, Weinberg CR, O’Connor JF et al. Incidence of early loss of pregnancy. N Engl J Med 319:189, 1988
Williams PM, Fletcher S. Health effects of prenatal radiation exposure. Am Fam Physician 82(5):488, 2010
Williams Z: Inducing tolerance to pregnancy. N Engl J Med 367(12):1159, 2012
Winikoff B, Dzuba IG, Creinin MD et al. Two distinct oral routes of misoprostol in mifepristone medical abortion: a randomized controlled trial. Obstet Gynecol 112(6):1303, 2008
Wo JY, Viswanathan AN: Impact of radiotherapy on fertility, pregnancy, and neonatal outcomes in female cancer patients. Int J Radiat Oncol Biol Phys 73(5):1304, 2009
Wong LF, Porter TF, Scott JR: Immunotherapy for recurrent miscarriage. Cochrane Database Syst Rev 10:CD000112, 2014
World Health Organization: Preventing unsafe abortion. 2018.
World Health Organization: The use of DDT in malaria vector control: WHO position statement Geneva, World Health Organization, 2011
Wu HL, Marwah S, Wang P et al. Misoprostol for medical treatment of missed abortion: a systematic review and network meta-analysis. Sci Rep 7(1): 1664, 2017
Wu J, Ma J, Bao C: Pregnancy outcomes among Chinese women with and without systemic lupus erythematosus: a retrospective cohort study. BMJ Open 8(4):e020909, 2018
Yan XC, Wang JH, Wang B et al. Study of human cytomegalovirus replication in body fluids, placental infection, and miscarriage during the first trimester of pregnancy. J Med Virol 87(6):1046, 2015
Yetman DL, Kutteh WH: Antiphospholipid antibody panels and recurrent pregnancy loss: prevalence of anticardiolipin antibodies compared with other antiphospholipid antibodies. Fertil Steril 66:540, 1996
Youssef A, Vermeulen N, Lashley EE et al. Comparison and appraisal of (inter)national recurrent pregnancy loss guidelines. Reprod Biomed Online 39(3):497, 2019
Zhang J, Gilles JM, Barnhart K et al. A comparison of medical management with misoprostol and surgical management for early pregnancy failure. N Engl J Med 353:761, 2005
Ziakas PD, Pavlou M, Voulgarelis M: Heparin treatment in antiphospholipid syndrome with recurrent pregnancy loss: a systematic review and meta-analysis. Obstet Gynecol 115(6):1256, 2010
Труды отечественных авторов при подготовке статей по гинекологии для пользователей сайта - не использовались, так как их вы всегда можете найти в библиотеках.
